Minimum import price set for Penicillin G, salts

New Delhi:  The Union government has set a minimum import price (MIP) for some key pharmaceutical inputs like penicillin G and its salts, 6 APA and amoxicillin.

According to a Directorate General of Foreign Trade (DGFT) notification, the import price for penicillin, a key raw material for antibiotics, is set at ₹2,216 per kg, for amoxicillin import price is fixed at ₹2,733 per kg and ₹3,405 per kg for 6-APA.

Government officials said a decision has been taken to combat low-cost imports from China, which may impact sustainability of domestic producers. However, smaller units in the industry say this decision may impact sustainability of domestic formulation producers.

“The decision has been taken after extensive meetings with industry. Henceforth, import of raw materials will not be allowed below MIP,” said a government official on condition of anonymity. China supplies roughly 70% of raw material consumed by Indian pharmaceutical industry, valued at $10-12 billion. The government had earlier launched a PLI scheme as part of its efforts to reduce India’s dependence on China for raw material and restore local manufacturing.

Price restrictions will stay in place for one year, according to the notification ET has seen. “However, this restriction will not be applicable for import by 100% export-oriented units (EOUs), units in the SEZ and imports under the advance authorisation scheme subject to the condition that imported inputs are not sold in the domestic tariff area (DTA), the notification dated January 29 said.

Several experts view the government’s move on MIP as balancing self-reliance with affordability. “The measure applies only to imports meant for domestic consumption and does not affect exports or re-exports, preserving India’s competitiveness while ensuring a level playing field at home,” said an industry expert.

In November, MIP of ₹1,174 per kg was set for sulphadiazine effective till September 30 next year.

Related Posts

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources